Back to Trials
NCT06728969NARecruitingAccepts Healthy Volunteers

A Comparative Study to Evaluate a Novel Algorithm As a Diagnostic Aid for ADHD in Youth Ages 6-17.

MindTension

Start Date

6/2/2024

Completion Date

6/1/2026

Summary

This study aims to demonstrate the accuracy of the MT1 algorithm using the MindTension biometric sensor device as a diagnostic aid for healthcare providers in diagnosing ADHD in youth ages ≥ 6 to ≤17 years.

Detailed Description

The study aims to demonstrate the accuracy of the MT1 algorithm. The output of the MT1 algorithm will be compared to a Gold Standard clinical diagnosis made by specialist clinician diagnosis supported by the Kiddie SADS Present and Lifetime semi-structured interview (K-SADS-PL) and norm-referenced measures of current ADHD symptom frequency and severity using the ADHD-RS-5 rating scale. Diagnosis will be scaled according to the Diagnostic and Statistical Manual of Mental Disorders- 5 (DSM-5) criteria, and made with agreement between two licensed specialists in ADHD (a Clinical Psychologist and a Psychiatrist). Further to the above, demonstrate that the agreement between the MT1 output and the specialist clinician diagnosis will be non-inferior to the level of agreement between the clinician diagnosis with the Test of Visual Attention (TOVA) FDA cleared device.

Eligibility Criteria

Age Range: 6 years to 17 years

Inclusion Criteria: 1. Parent provision of signed and dated informed consent form 2. Child stated willingness to comply with all study procedures and availability for the duration of the study 3. Any gender, aged 6 to 17 years 4. Stimulant naïve or willing to wash out of stimulant for 3 days (approximately 72 hours) prior to testing with biometric and performance devices (MindTension + TOVA) 5. ADHD Group: Diagnosed with symptoms consistent with ADHD as determined by Mini Kid + an ADHD-RS score of 1.5SD above mean for age and sex 6. Control group: No diagnosable disorder on the Mini kid, and an ADHD-RS score within 1SD of the mean for age and sex. Exclusion Criteria: 1. Current use of psychotropic medications that cannot be washed out in 3 days (approximately 72 hours) 2. Known current seizure disorder (history of febrile seizure allowed). 3. Presence of specific devices (e.g., cardiac pacemaker) that may interfere with the MindTension monitor 4. IQ\<70 by clinician judgment 5. Meeting FULL criteria for current PTSD, GAD, MDD, or any lifetime diagnosis of ASD, Bipolar disorder, or psychotic disorder that was, in the opinion of the investigator, correctly obtained. May have symptoms of anxiety or dysthymia/depression not meeting criteria for a full disorder, or disorders such as simple phobia 6. Deaf or hearing impaired, since this will make it difficult to hear and respond to the auditory stimuli. 7. Inability to complete the assessments. 8. Any other concerns in the judgment of the PI.

Interventions

DEVICE

MT1 Auditory startle response patterns analysis algorithm

DEVICE

T.O.V.A. Continuous Performance Test

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

ADHD

Locations

Icahn School of Medicine at Mount Sinai

New York, New York 10029

United States